Evidence map›Paper›PMID 42465328›Full record

ArticlebioRxiv : the preprint server for biology2026

SupeRJump: Determining normal and leukemic differentiation fate through semi-supervised jump diffusion modeling.

Michael Bowman, Roopsha Bandopadhyay, Varsha Singh, Maria Telpoukhovskaia, Robert Vander Velde, Sydney M Shaffer, Jennifer J Trowbridge, Robert L Bowman

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael BowmanDepartment of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0001-6092-4668
Roopsha BandopadhyayDepartment of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0009-0002-9982-9654
Varsha SinghDepartment of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-2761-7102
Maria TelpoukhovskaiaThe Jackson Laboratory, Bar Harbor; ME, 04609, USA.ORCID 0000-0002-5237-4042
Robert Vander VeldeDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-0776-6773
Sydney M ShafferDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-3539-9886
Jennifer J TrowbridgeThe Jackson Laboratory, Bar Harbor; ME, 04609, USA.ORCID 0000-0002-7636-9504
Robert L BowmanDepartment of Cancer Biology, Perelman Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-8294-8748

Funding

ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)UG1CA233332 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CAI, SHENG, LEVINE, ROSS L · 2019 to 2025
$6.2M
Integration of epigenetic and non-coding RNA mechanisms in leukemiaR37CA226433 · NCI · THOMAS JEFFERSON UNIVERSITY · PI MEYER, SARA E · 2018 to 2024
$2.5M
NCI NIH HHS R37 CA226433NCI NIH HHS UG1 CA233332
6 · The paper itself

Abstract

Single cell RNA-seq (scRNA) has provided unprecedented resolution into cellular and clonal heterogeneity. Computational approaches have enabled recovery of differentiation dynamics, yet current approaches do not evaluate discontinuous differentiation processes present in malignant leukemia. To address these gaps, we developed SupeRJump: a jump-drift-diffusion based supervised cell-fate model (https://github.com/namwob44/SupeRJump/). We deploy this approach in human bone marrow, murine aging hematopoiesis, and lentivirally barcoded mouse models of acute myeloid leukemia. Our framework introduces a semi-supervised pseudotime strategy to fit a jump-drift-diffusion model and batch correction for lineage fate predictions from absorbing Markov chains. We introduce metrics to quantify a cell's skewness toward particular lineages, transitions through intermediate progenitor states toward terminally differentiated states, and discontinuous transition dynamics. We use these metrics to identify cells preferentially biased for differentiation, their underlying transcriptional networks, and gene programs responsible for differentiation discontinuity.

Identifiers

PMID42465328
PMCPMC13370893

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.